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Abstract: Neutral liposomes (NLP) exhibit preferential localization in solid tumors based on the 
enhanced permeation and retention (EPR) effect. Cationic liposomes (CLP) have a propensity for 
localizing in newly formed tumor vessels and they have a potentially enhanced antitumor effect. 
However, an increased amount of cationic lipids in liposomes also induces aggregation through 
electrostatic interactions between the liposomes and the anionic species in the circulation, which 
results in a reduced EPR effect. Consequently, it is important to investigate the characteristics 
of liposomes with different surface potentials in vitro to achieve an optimal intratumoral dis-
tribution and antitumor effect in vivo. In this study, the authors evaluated the characteristics of 
doxorubicin (DOX)-loaded NLPs, CLPs, polyethylene glycol (PEG)-modified NLPs (NLP-PEG), 
and PEGylated CLPs (CLP-PEG) (ie, encapsulation efficacy, zeta potential, size, membrane 
fluidity, aggregation in serum, and uptake of liposomes into rat aortic endothelial cells (RAECs)) 
to further understand their influences on the pharmacokinetics, biodistribution, and antitumor 
therapy in vivo. The results showed that increased amounts of cationic lipids resulted in severe 
liposome aggregation in the presence of serum, yet it did not alter the membrane fluidity to a large 
extent. The uptake of liposomes into RAECs, visualized by confocal fluorescence microscopy, 
confirmed the rapid uptake of CLP by the endothelial cells compared with NLP. However, the 
pharmacokinetics, biodistribution and anticancer efficacies of these liposomes in vivo revealed 
that the CLP with highly positive surface potentials exhibited reduced circulation times and poor 
distribution in tumors. The NLP-PEG exhibited the highest anticancer efficacy; CLP-PEG, the 
second highest; and CLP with the most positive surface potential, the lowest. These phenomena 
were mostly due to the rapid aggregation in serum and subsequent accumulation in the lungs 
upon the intravenous injection of the CLP. Caution should be exercised when chemotherapeutic 
drugs are loaded into CLP for tumor therapy.
Keywords: cationic liposomes, PEGylation, electrostatic interaction, aggregation, anticancer 
efficacy, biodistribution
Introduction
Liposomes are widely recognized as potential anticancer chemotherapeutic agent 
carriers. Large arrays of drugs have been encapsulated in neutral or sterically stable 
liposomes for cancer treatment. Some anticancer liposomal drug delivery systems 
are already approved for clinical use.1 Neutral liposomes (NLP) exhibit preferential 
localization in solid tumors based on the enhanced permeation and retention (EPR) 
effect, which relies on the gradual passive accumulation of liposomes in the tumor.1,2 
The liposomes modified with polyethylene glycol (PEG) (Stealth liposomes; 
Liposome Technology, Inc., Menlo Park, CA) may enhance the EPR effect, which 
relies on extending the circulation time and escaping from the reticuloendothelial International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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system (RES).3,4 The PEGylation of liposomes also prevents 
aggregation and aids the formation of small, monodisperse 
particles.
Cationic liposomes (CLP) are commonly used for 
delivering genes by utilizing the electrostatics between posi-
tively charged lipids and negatively charged nucleic acids. 
Recent studies have shown that CLP have a propensity for 
localizing in newly formed tumor vessels; however, nei-
ther the mechanism behind this selectivity nor the optimal 
formulation to maximize this effect has been identified. 
There are anionic sites in the angiogenic endothelial cells 
(such as anionic phospholipids, proteoglycans, hypergly-
cosylated and hypersialylated membrane proteins,5–7 and 
so forth) that may be the selective targeting sites. It has 
recently been reported that paclitaxel, doxorubicin, and 
oxaliplatin encapsulated in CLP exhibited improved anti-
tumor efficacy associated with impaired function of the 
tumor microvasculature.8–11 Campbell et al12 stated that a 
positive charge on liposomes is required to enhance their 
interactions with the glycoprotein layer of the endothelium. 
However, unshielded CLP or lipoplexes themselves are 
well known to possess poor physicochemical characteristics 
for systemic delivery. Their positive surface charge leads 
to nonspecific interactions with the anionic species in the 
blood, which results in rapid clearance from the circula-
tion by the RES13–15 and a reduced EPR effect.10,16,17 It was 
hypothesized that an increased amount of cationic lipids in 
liposomes may lead to a higher affinity for the angiogenic 
endothelial cells, which may enhance the anticancer effects. 
However, it may also enhance the aggregation of CLP in 
the bloodstream through electrostatic interactions with the 
anionic species in the blood and enhancing uptake by the 
RES. The two effects are interrelated in adverse and/or 
more complicated form to affect the fate of CLP in vivo. 
Consequently, it is important to investigate the in vitro and 
in vivo characteristics of liposomes with different surface 
potentials to achieve an optimal intratumoral distribution 
and antitumor effect in vivo.
In this study, the authors evaluated doxorubicin (DOX)-
loaded NLP, CLP, PEGylated NLP (NLP-PEG), and PEGy-
lated CLP (CLP-PEG) by investigating their characteristics 
in vitro (ie, encapsulation efficacy, zeta potential, size, 
membrane fluidity, and aggregation in serum) to further 
understand their influences on tumor therapy. Using confo-
cal fluorescence microscopy, the authors confirmed the rapid 
uptake of CLP-PEG and CLP by endothelial cells in vitro, 
compared with NLP. The pharmacokinetics, distribution, and 
anticancer efficacies of the NLP and CLP in tumor-bearing 
mice were also investigated. The in vivo results revealed that 
the PEGylated liposomes had better anticancer efficacy.
Materials and methods
Materials
L-α-Dipalmitoylphosphatidylcholine (DPPC) was purchased 
from NOF Corporation (Tokyo, Japan) and cholesterol 
(Chol) was obtained from Wako Pure Chemical Indus-
tries, Ltd (Osaka, Japan). 3β-[N-[2-(N, N-dimethylamino)
ethyl]carbamoyl] cholesterol (DC-Chol) was synthesized 
as described.18 1,2-Distearoyl-sn-glycero-3-phosphoetha-
nolamine-N-[poly (ethylene glycol)2000] (DSPE-PEG) was 
purchased from Northern Lipids Inc (Burnaby, British 
Columbia, Canada). Zhejiang Hisun Pharmaceutical Co, 
Ltd (Taizhou Zhejiang, China) kindly donated the DOX. 
1,6-Diphenyl-1,3,5-hexatriene (DPH) and daunorubicin 
hydrochloride (DAU) were purchased from Sigma-Aldrich 
(St Louis, MO). Newborn calf serum (NCS) was obtained 
from HyColone Laboratories, Inc (Logan, UT). All other 
chemicals were commercial products of analytical grade. The 
hepatocarcinoma (H22) cells and sarcoma 180 (S180) cells 
were a kind gift from the Pharmacology Department, School 
of Pharmaceutical Sciences, Peking University.
Liposome preparation  
and characterization
Several liposomes with a total lipid content of 20 µmol/mL 
were prepared using the film dispersion method. The ratio in 
each liposome denotation shown in Table 1 refers to the molar 
ratio of neutral lipid to cationic lipid: LP (neutral liposomes 
only containing DPPC without chol and DC-chol) 10:0, NLP 
10:0, NLP 10:0-PEG, CLP 9:1, CLP 3:1, CLP 3:1-PEG, CLP 
5:5, and CLP 5:5-PEG.
The lipids were dissolved in one aliquot of chloroform 
and one aliquot of methanol. The solvent was evaporated 
under vacuum in a rotary evaporator at 45°C until a thin lipid 
film was formed. Drying the film under vacuum for 1 hour 
further eliminated solvent traces. Liposomes were formed 
upon the addition of 150 mM ammonium sulfate to the flask 
followed by bath sonication at 50°C for 10 minutes. The 
liposome dispersion was further probe sonicated in ice water 
for 3 minutes and extruded through a 200 nm polycarbonate 
membrane (Nuclepore Corp, Pleasanton, CA) at about 60°C 
to obtain a homogeneous liposome suspension.
DOX was loaded in the liposomes by remote loading 
using an ammonium sulfate gradient. Briefly, liposomes 
dispersed in a 150 mM ammonium sulfate solution were 
loaded onto a Sephadex G-50 column (Pharmacia, Uppsala, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Sweden) and eluted with phosphate-buffered saline (PBS; 
138 mM sodium chloride (NaCl), 2.68 mM potassium chlo-
ride, 9.69 mM disodium hydrogen phosphate monohydrate, 
1.46 mM potassium dihydrogen phosphate (pH 7.4)) to 
achieve an ammonium sulfate gradient. DOX was then added 
to the liposome suspension to attain a drug-to-lipid molar 
ratio of 1:20 (w/w), and the samples were incubated in a 
water bath at 60°C for 10 minutes with continual shaking to 
provide optimal loading conditions. The liposomes loaded 
with DOX were extruded through a 200 nm polycarbonate 
membrane and stored at 4°C.
To determine the DOX encapsulation efficiency, free DOX 
was separated from the liposomal DOX by a Sephadex G-50 
column eluted with PBS. The concentration of liposome-en-
trapped DOX was measured using a fluorescence spectropho-
tometer (λex: 480 nm; λem: 590 nm) (RF-5301PC; Shimadzu, 
Kyoto, Japan) following the destruction of the liposomes by 
adding acidified isopropanol (0.75 N hydrochloric acid). The 
encapsulation efficiency is expressed as the percentage of DOX 
loaded into liposomes after the removal of the free DOX by gel 
filtration. The particle size and zeta potential of these liposomes 
were analyzed by photon correlation spectroscopy and laser 
Doppler microelectrophoresis using a Malvern Zetasizer 3000 
(Malvern Instruments Ltd, Worcestershire, UK).
Liposome turbidity in Ncs and saline
The turbidity of liposome suspensions in 50% NCS and in 
saline (0.9% NaCl solution) was studied by determining the 
absorbance at 550 nm of five blank liposome suspensions of 
NLP 10:0, CLP 9:1, CLP 3:3, CLP 5:5, or CLP 5:5-PEG con-
taining the same lipid concentration of 16 µmol/mL at various 
time points and at room temperature (27.5°C). Fifty percent 
NCS was treated as a control following the previous procedure. 
The relative absorbance values (%) were calculated according 
to At/A0 × 100, where A0 denotes the initial absorbance of the 
sample and At denotes the absorbance at a given time (t) upon 
mixing the liposomes with saline or with NCS.
Measurement of the fluorescence  
polarization of liposomal membranes
DPH, a fluorescent probe, was dissolved in tetrahydrofuran 
at a 2 mM concentration and was added to lipids dissolved 
in chloroform and methanol at a DPH-to-lipid molar ratio of 
1:200 before a thin film formed. The liposomes were prepared 
by the method described at a total lipid concentration of 
4 mM in PBS. The fluorescence intensities were measured at 
30°C–65°C with a fluorescence spectrophotometer (F-45000; 
Hitachi High-Technologies Corporation, Tokyo, Japan) at 
350 nm for excitation and 450 nm for emission. All measure-
ments were performed in quartz cuvettes thermostatized by a 
circulating water bath (PolyScience, Niles, IL) that was con-
nected to the cuvette holder. The fluorescence polarization 
(p) can be calculated using the following equation:
  p
IG
IG I
VV VH
VV VH
=
−×
+×
I .
In this equation, IVV denotes the fluorescence intensities of 
the emitted light polarized parallel to the vertically polarized 
exciting light and IVH denotes the fluorescence intensities of 
the emitted light polarized perpendicular to the vertically 
polarized exciting light. G I = IHV HH /  is the instrumental grat-
ing factor,19 where IHV and IHH are the fluorescence intensities 
of the emitted light polarized perpendicular and parallel to 
the horizontally polarized exciting light.
Table 1 Liposome formulations and characteristics
Liposome  
denotations
Liposome formulation  
(molar ratio)*
Encapsulation  
efficiency (%)
Zeta potential  
(mV)
Size  
(nm)
Polydispersity 
index
DPPC Chol DC-Chol DSPE-PEG
LP 10:0 100 0 0 0 Nr  + 0.76 ± 0.55 124 0.398
NLP 10:0 50 50 0 0 102.7 ± 5.3  - 7.31 ± 1.74 141 ± 35 0.384 ± 0.121
NLP 10:0-Peg 45 50 0 5   91.4 ± 1.6  - 3.99 ± 0.42   86 ± 4 0.171 ± 0.015
cLP 9:1 50 40 10 0   91.3 ± 2.1  + 5.58 ± 1.46 131 ± 19 0.404 ± 0.106
cLP 3:1 50 25 25 0   93.3 ± 2.7 +11.80 ± 1.38 101 ± 11 0.222 ± 0.050
cLP 3:1-Peg 47.5 25 25 2.5   97.8 ± 3.6  + 1.33 ± 1.27   99 ± 13 0.202 ± 0.058
cLP 5:5 50 0 50 0   92.4 ± 7.8 +24.25 ± 1.93   95 ± 14 0.299 ± 0.078
cLP 5:5-Peg 45 0 50 5   96.0 ± 1.2  + 3.82 ± 0.98 102 ± 37 0.198 ± 0.033
Notes: *All liposomes were prepared by the same method with the same total lipid molar concentration. When loaded with DOX, the DOX concentration was 0.5 mg/mL 
with a DOX-to-lipid mass ratio of 1:20. The particle size and zeta potential were measured in phosphate-buffered saline (ph 7.4). Data represent the mean plus or minus 
standard deviation (n = 3–5).
Abbreviations:  chol,  cholesterol;  cLP,  cationic  liposome;  Dc-chol,  3β-[N-[2-(N,  N-dimethylamino)ethyl]carbamoyl]  cholesterol;  DOX,  doxorubicin;  DPPc,  L-α-
dipalmitoylphosphatidylcholine; DsPe-Peg, 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly (ethylene glycol)2000]; NLP, neutral liposome; LP, neutral liposomes 
without cholesterol; Nr, not reported; Peg, polyethylene glycol.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cell culture and intracellular uptake  
of liposomes
The Sprague Dawley rat aortic endothelial cells (RAECs) 
were isolated according to the reported procedure20,21 and were 
cultured in RPMI 1640 medium (Gibco Invitrogen, Grand 
Island, NY) supplemented with 10% (v/v) heat-inactivated 
NCS, 200 U/mL penicillin, 100 U/mL streptomycin, and 
0.11 mg/mL sodium pyruvate. Cells were maintained in a 
5% carbon dioxide atmosphere at 37°C. RAECs from pas-
sages three and four were used for all experiments.
Sterile coverslips were placed in six-well plates. RAECs 
were seeded at a concentration of 2 × 104 per mL in the same 
six-well plates. Following an incubation period of 24 hours 
at 37°C in RPMI 1640 medium containing 10% NCS, the 
medium was replaced with serum-free RPMI 1640 medium, 
which was followed by the addition of DOX-loaded lipo-
somes or free DOX saline solution (DOX final concentra-
tion, 10 µg/mL; lipid final concentration, 2.7 µmol/mL) to 
each well. The cells were incubated for additional times 
(15 minutes, 30 minutes, 1 hour, 4 hours) with liposomes 
and washed with PBS three times to remove unassociated 
liposomes. The cells were then fixed at room temperature in 
4% paraformaldehyde for 20 minutes, which was followed 
by adding 0.2% Triton X-100 (Amresco LLC, OH) to disrupt 
the cell membranes. After washing with PBS three times, the 
cells were treated with diaminophenylindole (DAPI) (Sigma-
Aldrich, St Louis, MO) to stain the cell nuclei. The coverslip 
from each well was mounted onto a glass microslide with 
80% fluorescence-free glycerol mounting medium. Finally, 
the interaction of liposomes with RAECs and the intracellular 
uptake was observed using a confocal microscope (Leica 
Microsystems GmbH, Wetzlar, Germany) to visualize DAPI 
(345/661 nm) and DOX (488/590 nm).
Animal and tumor models
Kunming (KM) mice (∼20 g bw), purchased from Peking 
University Animal Laboratory, were chosen to establish the 
tumor-bearing model. In vivo experiments were carried out 
according to institutional and governmental guidelines. The 
animals were housed in cages and had free access to tap water 
and standard laboratory food throughout the experiments.
The H22 cells were cultured in the ascites of the KM 
male mice for 7–10 days. Subsequently, the ascitic fluid 
was removed and diluted with sterile saline to obtain an H22 
concentration of 1 × 107 cell/mL. The solid tumor model 
was prepared by the subcutaneous inoculation of a 0.2 mL 
suspension containing 2 × 106 H22 cells on the right hind 
limb of each mouse. The H22 solid tumor-bearing mice 
were used in experiments for the pharmacokinetics and 
biodistribution studies when the tumor reached a diameter 
of approximately 8 mm.
The S180 cell suspension was the ascitic fluid of KM mice 
diluted with Dulbecco’s modified Eagle’s medium (Gibco, 
Invitrogen, Carlsbad, CA). The S180 cells (5 × 106/0.2 mL) 
were implanted by subcutaneous injection in the armpits of 
female KM mice to establish the S180 tumor model. The 
S180 tumor-bearing mice were used in the experiments for 
antitumor effects.
Pharmacokinetics and biodistribution  
of liposomes in vivo
The pharmacokinetics and biodistribution studies were car-
ried out on the female KM mice bearing H22 tumors. Free 
DOX or DOX-loaded liposomes (NLP 10:0, CLP 9:1, CLP 
5:5, or CLP 5:5-PEG) with the same DOX concentration 
of 0.5 mg/mL were administered to groups of six mice by 
intravenous injection into the tail vein at a dose of 5 mg/kg 
of body weight. After the injection, blood samples were col-
lected under ether anesthesia at 0.083, 0.5, 1, 4, 8, 12, and 
24 hours. The blood samples were placed in heparinized vials 
and centrifuged at 5000 rpm for 10 minutes. The plasma was 
collected and stored at -20°C until analyzed. Animals were 
then sacrificed by cervical dislocation immediately after 
blood was extracted at different time points, and the heart, 
liver, spleen, kidney, lung, and tumor were collected, rinsed 
with saline, and stored at -20°C until analyzed.
An extraction protocol modified from the reported 
method22,23 was used for the plasma and tissue samples. 
Briefly, approximately 0.2 g tissue was first homogenized 
in 400 µL PBS. An aliquot of this 400 µL homogenate or 
200 µL plasma sample was transferred to a glass centrifugal 
tube, which was followed by the addition of 50 µL DAU 
(40 µg/mL) as an internal standard. Then, 5 mL organic 
solvent containing methanol and chloroform (1:4, v/v) was 
added to the homogenate or to the plasma sample, which 
was subsequently vortexed for 1 minute and centrifuged at 
4000 rpm for 20 minutes. The lower organic solvent layer was 
collected and dried in a water bath at 40°C under nitrogen. 
Finally, it was redissolved in the mobile phase solution and 
stored at -20°C until analyzed by high-performance liquid 
chromatography (HPLC).
For HPLC analysis, the C18 reverse-phase column was 
equilibrated with a mobile phase of methanol and water 
(1:1, v/v) acidified by 85% phosphoric acid to reach a final pH 
of 3.1. The flow rate was 1 mL/min, the ultraviolet detection 
wavelength was 233 nm, and the room temperature was 27°C. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The noncompartmental analysis was utilized for simulating 
the pharmacokinetics and distribution of free DOX or DOX-
loaded liposomes in H22 tumor-bearing mice. The mean 
values of each group were used in the noncompartmental 
analysis.
Antitumor effects in vivo
Sixty S180 tumor-bearing KM mice were randomly divided 
into six groups. The DOX-loaded liposomes (NLP 10:0, NLP 
10:0-PEG, CLP 3:1, or CLP 3:1-PEG) with the same DOX 
concentration of 0.5 mg/mL were intravenously injected into 
the tail vein at a dose of 5 mg/kg of body weight on days 
2, 4, and 6 after the tumor implantation. The DOX solution 
in normal saline (free DOX; the positive control) and the 
normal saline (the negative control) were also administered 
on the same schedule. The deaths of the S180 tumor-bearing 
mice were recorded.
statistical analysis
Data were expressed as the mean plus or minus the standard 
deviation. The statistical analysis was carried out using SPSS 
software (v 15.0; SPSS Inc, Chicago, IL). The Kaplan–Meier 
survival methodology was used for analysis of the survival 
rate data. Other data were analyzed using the unpaired 
Student’s t-test. Generally, P , 0.05 was considered to be 
statistically significant.
Results and discussion
Liposome characterization
Vesicle size, surface charge, liposome composition, and lipid 
dose are major determinants for the fate of intravenously 
administered liposomes. Small, PEGylated liposomes typi-
cally exhibit a decreased rate of RES uptake and increased 
circulation time.24
The DOX encapsulation efficiency, size, and zeta poten-
tial of the DOX-loaded liposomes are shown in Table 1. 
The DOX encapsulation efficiency of all liposomes was 
above 90%, and the small differences may be due to prepa-
ration variation. The liposome sizes were approximately 
85–140 nm. The electronegativity or electropositivity at the 
liposome surfaces, as reflected in the zeta potential values, 
was affected by the liposome composition. The lower negative 
or positive zeta potential values were obtained for LP 10:0, 
NLP 10:0, and NLP 10:0-PEG. The liposomes containing the 
cationic lipid DC-Chol exhibited positive zeta   potentials. The 
increase in the amount of DC-Chol undoubtedly enhanced 
the positive surface charge of the liposome membrane. 
The addition of DSPE-PEG in the liposomes reduced the 
absolute value of the zeta potentials. This phenomenon may 
be   attributed to the PEG coating, which is a hydrophilic layer 
formed around the liposome membranes that shifts the shear 
plane of the liposomes, thus resulting in a decrease in the 
absolute value of the zeta potential. Long-chain PEG was 
reported to prolong the blood circulation time in vivo, which 
led to an increased accumulation in the tumor.
The stability of some liposomes (NLP 10:0, CLP 9:1, 
CLP 5:5, and CLP 5:5-PEG) stored at 4°C was determined 
every week using the encapsulation efficiencies, sizes, and 
zeta potentials as indicators. The encapsulation efficiencies, 
sizes, and zeta potentials of the liposomes fluctuated slightly 
over 28 days but did not significantly change, and no visible 
sedimentation was observed. The results suggested that the 
DOX-loaded liposomes would be stable for at least 28 days 
at 4°C.
Liposome aggregation in Ncs
There are anionic species in serum that may interact with the 
positively charged membranes of CLP. Thus, the interactions 
between anionic substances and liposome membranes may 
result in the aggregation of liposomes in serum. The sedimen-
tation of agglomerates occurs readily compared with that of 
nonaggregated liposomes. Thus, the relative absorbance (%) 
of a liposome suspension at 550 nm reflects the turbidity 
change.25 Figure 1 shows the relative absorbance (%) of 
liposomes in saline and in 50% NCS at the indicated times. 
The relative absorbance of liposomes in saline (Figure 1A) 
was measured to determine the influence of liposome 
self-sedimentation on aggregation. The results showed that the 
relative absorbance values of NLP 10:0 and CLP 9:1 changed 
over time, while those of CLP 3:1, CLP 5:5, and CLP 5:5-PEG 
were constant for up to 12 hours at room temperature. The 
reduction of absorbance values for NLP 10:0 and CLP 9:1 
indicated that NLP 10:0 and CLP 9:1 self-aggregated due 
to the relatively neutral charges on the membrane surfaces. 
In contrast, CLP 3:1 and CLP 5:5, which have highly positive 
surface charges and strong self-repulsion forces, tended to be 
stable in saline. The CLP 5:5-PEG exhibited a similar profile 
to CLP 5:5 because of its outer hydrophilic PEG brush and 
in spite of the relatively neutral surface charges. However, in 
NCS (Figure 1B), CLP 3:1 and CLP 5:5 (which contained 
25 mol% and 50 mol% of cationic lipids, respectively, and 
thus exhibited highly positive zeta potentials) became severely 
aggregated with the anionic species in serum, which was 
followed by a drastic fall in absorbance at 4 hours due to 
aggregate sedimentation. Because of their relatively negative 
or slightly positive charges on the membrane surfaces, the International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 1 Relative absorbance values of five blank liposomes in (A) saline and (B) 50% newborn calf serum (Ncs) at 550 nm. Blank liposomes were incubated with the same 
volumes of Ncs and saline at room temperature, and their absorbance values at 550 nm were measured at the indicated time points.
Note: The relative absorbance values of the five blank liposomes were calculated as At/A0 × 100, where A0 denotes the initial absorbance of the sample and At denotes the 
absorbance at a given time (t) upon mixing the liposomes with saline or with Ncs.
Abbreviations: cLP, cationic liposome; NLP, neutral liposome; Peg, polyethylene glycol.
relative absorbance values of NLP 10:0, CLP 9:1, and CLP 
5:5-PEG did not change significantly over time.
These results support the authors’ hypothesis that there 
are interactions between the anionic species in serum and 
the CLP. Based on this sedimentation result and the stabil-
ity of the liposomes at 4°C, it may be concluded that the 
CLP have good physical stability in saline but they interact 
strongly with the anionic substances in serum.   Aggregations 
increase with the amount of cationic lipids in the mem-
brane surface, which implies that CLP are unstable in vivo 
when they have a highly positive charge on the membrane 
surface. Modifying CLP with PEG may shade the positive 
charge and improve the stability of liposomes in serum 
and in vivo.
Effect of lipid composition on the fluidity 
of liposomal membranes
The results of the fluorescence polarization of DPH provide 
information on the orientation of the acyl chain in the lipo-
somal bilayers. According to the Perrin-Webber equation, 
fluorescence polarization is correlated to the membrane 
fluidity near the fluorescent probe. When DPH movement is 
restricted in the gel state of the lipid, the liposomes exhibit 
high fluorescence polarization. A decrease in fluidity leads 
to an increase in fluorescence polarization.
The variation in the fluorescence polarization of DPH with 
temperature is shown in Figure 2. The fluorescence polar-
ization of LP 10:0 (consisting of only DPPC)   significantly 
decreased from 0.5666 at 40°C to 0.4703 at 45°C, which 
is in accordance with the phase transition temperature of 
DPPC from the gel to liquid crystalline state at 41°C. The 
same result had been observed by Qi et al.25 The addition 
of Chol and DC-Chol mitigated the fluidity changes in the 
liposomal membranes. The fluorescence polarization of CLP 
9:1 gradually decreased with temperature from 35°C to 65°C, 
while that of CLP 3:1 decreased and reached a plateau in 
the range of 45°C–55°C, which indicates there are two dif-
ferent phase transition temperatures because of its varying 
lipid composition. Notably, in the range of 35°C–40°C, the 
samples ranked in fluorescence polarization as follows: CLP 
3:1-PEG . CLP 5:5-PEG . CLP 9:1 . CLP 3:1 . CLP 5:5. 
This indicated that, at the gel state, the increasing content of 
DC-Chol in the liposomal membranes led to the increase in 
fluidity, while the inclusion of PEG may reduce membrane 
fluidity. The results suggested that the addition of DC-Chol 
and a subsequent increase in membrane fluidity would likely 
lead to an increase in DOX leakage from these liposomes, 
while adding PEG to the membrane may reduce the leakage 
to some extent. The conclusion was consistent with the obser-
vation on DOX leakage in vitro in a previously published 
article by the authors.26
The presence of Chol exerts a profound influence on 
the properties of the lipid bilayers of the liposomes. The 
DC-Chol may have the similar influence with Chol on lipid 
bilayers of the liposomes. The addition of Chol is necessary 
in order to prevent the leakage of the encapsulated drug International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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from the liposomes made from unsaturated lipids. Chol 
molecules fill in the free space formed because of the kink 
in the chain of the unsaturated lipids, and this will decrease 
the flexibility of the surrounding lipid chains. This interac-
tion also increases the mechanical rigidity of fluid bilayers 
and decreases their lateral diffusion. In contrast, the addition 
of Chol to gel-phase bilayers disrupts local packing orders, 
increases the diffusion coefficient, and decreases the elastic 
modulus. One of the main reasons for the addition of Chol 
to liposomes made from saturated lipids is to decrease the 
phase transition temperature. The existence of the phase-
separated domains makes the liposomes unstable upon the 
phase transition temperature, and therefore the liposomes 
release their content upon a temperature trigger. The addition 
of Chol to gel-phase liposomes will increase the fluidity of 
the membrane and therefore all the gaps and imperfections 
formed in the lipid bilayers because of the heat trigger will 
be healed immediately; this will prevent the liposomes 
from leaking more of their content upon trigger, and this 
is undesirable.
Intracellular uptake of liposomes 
observed by confocal fluorescence 
microscopy
Confocal fluorescence microscopy was used to evaluate the 
liposomal localization in RAECs (see Figure 3). The red areas 
represent the DOX localization, the blue areas indicate the 
cell nuclei stained by DAPI, and the pink areas represent the 
localization of DOX in the nuclei.
Free DOX was immediately taken up by RAECs and 
localized in the nuclei and cytoplasm because of its diffusion 
across the plasma membrane. NLP 10:0 was taken up slowly, 
and there was an insignificant amount of DOX in the nuclei 
after 4 hours of incubation. The weak cellular uptake of NLP 
10:0 by RAECs may be due to the anionic surface charges 
of NLP 10:0, which induce electrostatic repulsions with the 
cellular membrane. The CLP demonstrated an enhanced 
cellular uptake by RAECs compared with NLP 10:0, and 
their intracellular uptake varied directly with the amount of 
cationic lipids. This may be because of the positive charge 
of the CLP, which can induce electrostatic interactions with 
cells and facilitate DOX release into the cytosol by endosomal 
escape.10,27,28
Different lipids and cell types may result in different rates 
of intracellular uptake. This study confirmed that RAECs 
may readily take up CLP and PEGylated liposomes. There 
are anionic sites within angiogenic endothelial cells such as 
anionic phospholipids, proteoglycans, and hyperglycosy-
lated and hypersialylated membrane proteins.5–7 CLP were 
taken up via endocytosis and membrane fusion29 in a non-
specific pattern involving electrostatic interactions between 
the positively charged liposomes and the negatively charged 
cell surfaces in the absence of serum.12,30 Meanwhile, cat-
ionic lipids were reported31 to destabilize the endosomal 
membrane, leading to faster leakage of the loaded drug into 
the cytoplasm. These may be the reasons for the rapid local-
ization of DOX from the CLP to the nuclei and cytoplasm 
of the endothelial cells.
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Pharmacokinetics and biodistribution 
studies of liposomes in tumor-bearing mice
The 24-hour profiles of the DOX concentrations in the plasma 
of H22 tumor-bearing mice after the intravenous injection 
of free DOX, NLP 10:0, CLP 9:1, CLP 5:5, or CLP 5:5-
PEG are shown in Figure 4. The concentration of free DOX 
drastically decreased within 30 minutes, because of its fast 
clearance from the circulation. NLP 10:0, CLP 9:1, and CLP 
5:5-PEG exhibited long circulation times compared with free 
DOX. However, CLP 5:5, which exhibited the most positive 
zeta potential value, attained the lowest concentration after 
injection (even lower than the concentration of free DOX) 
CLP 5:5-PEG 
Free DOX     
NLP 10:0
CLP 3:1
CLP 5:5
CLP 9:1
15 minutes 30 minutes1  hours 4 hours
40.00 µm 20.00 µm 40.00 µm 40.00 µm
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40.00 µm 40.00 µm
40.00 µm 40.00 µm 40.00 µm 20.00 µm
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40.00 µm 40.00 µm
Figure 3 confocal micrographs showing the intracellular uptake of liposomes by rat aortic endothelial cells (rAecs). rAecs were incubated with different doxorubicin 
(DOX)-loaded liposomes, or free DOX as a control, for 15 and 30 minutes and 1 and 4 hours. The nuclei were stained by diaminophenylindole (shown in blue), and DOX 
(shown in red) is intrinsically fluorescent.
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and was not detected after 8 hours post injection. The phe-
nomenon may be explained by the severe aggregation of CLP 
5:5 with anionic species in the blood (see Figure 1), which 
accelerates the liposome clearance from the bloodstream. 
Among all the liposome preparations, NLP 10:0 attained 
the highest concentration after intravenous injection and the 
longest circulation time.
The pharmacokinetics parameters of the DOX-loaded 
liposomes and free DOX, which were calculated according 
to a noncompartmental model using WinNonlin software 
(WinNonlin Professional, v 3.1; Pharsight Corp., Mountain 
View, CA), are summarized in Table 2. Except for CLP 5:5, 
the DOX-loaded liposomes achieved longer performance 
in maximum plasma concentration (Cmax), area under the 
concentration-time curve (AUC), and mean residence time 
(MRT) than free DOX. Notably, NLP 10:0 exhibited the 
largest AUC0–t value. The samples ranked in MRT0–t as 
follows: NLP 10:0 . CLP 5:5-PEG . CLP 3:1 . free 
DOX . CLP 5:5. However, regarding the elimination rate 
(λ) from the bloodstream, CLP 5:5-PEG exhibited the slowest 
λ (0.04 hours-1) and longest half-life (18.06 hours), which 
implied a long circulation time.
The distributions of free DOX and four DOX-loaded 
liposomes in the blood, liver, spleen, lung, kidney, heart, 
and tumor that calculated from the AUC of different tissues 
on 0, 0.083, 0.5, 1, 4, 8, 12, and 24 hours using the linear 
trapezoidal rule are presented in Figure 5. CLP 5:5 attained 
a dramatically high distribution in the lung and smaller 
distributions in the liver, spleen, kidney, blood, and tumor 
compared with the tissue distributions of NLP 10:0, CLP 9:1, 
and CLP 5:5-PEG. The phenomena were attributed to the 
lung capture of the aggregates of the anionic species in the 
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Table 2 Pharmacokinetic parameters of free doxorubicin (DOX) and DOX-loaded liposomes
Parameter* Units DOX NLP 10:0 CLP 9:1 CLP 5:5 CLP 5:5-PEG
cmax µg/mL 6.96 59.94 12.70 0.30 43.49
λ 1/h 0.11 0.08 0.15 0.19 0.04
t1/2 h 6.30 9.08 4.51 3.67 18.06
AUc0–t h ⋅ µg/mL 3.77 387.93 85.92 0.35 36.64
MrT0–t h 3.13 6.68 5.59 0.98 6.19
Note: *Parameters were calculated using WinNonlin software (WinNonlin Professional, v 3.1; Pharsight corp., Mountain View, cA) and a noncompartmental model.
Abbreviations: λ, first-order elimination rate constant; AUC0–t, area under the concentration-time curve from the initial time to the time of the last observation, calculated 
using the linear trapezoidal rule; cLP, cationic liposome; cmax, maximum plasma concentration; MrT0–t, mean residence time from the initial time to the time of the last 
measurable concentration; NLP, neutral liposome; Peg, polyethylene glycol; t1/2, half-life.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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blood and the CLPs. Regarding accumulation in the tumor, 
NLP 10:0 and CLP 5:5-PEG attained higher distributions 
than CLP 9:1 and CLP 5:5, which revealed that the NLPs 
and CLP-PEG were advantageous for enhancing the lipo-
some accumulation in the tumor. When the positive surface 
potential is high, CLPs will readily aggregate in the serum 
(see Figure 1) and this will result in lung accumulation or 
embolism (see Figure 5), which is in accordance with some 
previous reports.12,15 The PEGylation of CLP 5:5 may shield 
the cationic sites on the liposomal surfaces and lower the 
surface potential; thus, CLP 5:5-PEG exhibited more stable 
profiles in vitro and in vivo and achieved better DOX accu-
mulation in tumors than CLP 5:5.
Therapeutic efficacy of liposomes
Every DOX therapeutic group produced fewer tumors than 
the negative control group (treatment with saline) in the S180 
tumor-bearing mice model (P , 0.01) (see Figure 6). The 
PEGylated liposomes (NLP-PEG and CLP-PEG) showed 
significant difference compared with the non-PEGylated 
liposomes (NLP and CLP) (P , 0.05) and saline (P , 0.01). 
The group treated with NLP 10:0-PEG exhibited the lon-
gest mean survival time. Comparing the comprehensive 
effect of every formulation, the authors conclude that the 
formulations rank in antitumor activities as follows: NLP 
10:0-PEG $ CLP 3:1-PEG . CLP 3:1 ≈ NLP 10:0 ≈ free 
DOX . saline. The PEGylation of NLPs and CLPs may 
enhance the antitumor effects for liposomes, with the best 
results obtained using NLP-PEG, although there was no 
significant difference between the NLP 10:0-PEG and CLP 
3:1-PEG. It was anticipated that CLP 5:5, which exhibited 
the highest positive charge, would not exhibit good antitumor 
activity in this experiment because of the poor pharmacoki-
netic parameters and distribution in vivo (see Table 2 and 
Figure 5), so, for economical purposes, the authors only used 
CLP 3:1 and CLP 3:1-PEG.
The elimination of liposomes from the systemic circula-
tion is a key issue affecting the therapeutic effect. PEGyla-
tion has been demonstrated to be an efficient approach to 
minimizing the interaction of conventional liposomes with 
the serum proteins and cells of the mononuclear phagocyte 
system in the liver and spleen, thus prolonging the plasma 
circulation time of the liposomes.32,33 Some researchers have 
reported that PEG concentrations of $6 mol% shielded the 
electric surface potential of CLPs and that a higher con-
centration (15 mol%) fully abolished the effect of charged 
groups on the liposome surface.34 NLP-PEG and CLP-PEG 
circulated longer and accumulated in the tumor in greater 
amounts because of the EPR effect. Subsequent to inter-
acting with the endothelium through anionic sites on the 
luminal surfaces of the vessels, cationic drug carriers may 
be internalized by endothelial cells through endocytosis or 
extravasation via endothelial fenestrae. Despite the remark-
able targeting of cationic liposomes to tumor vessels, this 
study found that a long circulation time in the bloodstream 
was still vital for achieving a good distribution in the tumor, 
because the NLPs and CLP-PEG achieved higher AUC and 
MRT values in the plasma (see Table 2) and delivered the 
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largest amount of drug to the tumors (see Figure 5), whereas 
the CLP 5:5 exhibited high absorption of anionic proteins 
and were rapidly cleared from the circulation system (see 
Figures 1 and 5).
CLP-PEG have provided researchers with an opportunity 
to exploit the leaky tumor vasculature for cancer treatment. 
CLP-PEG may achieve better efficacy in suppressing tumor 
growth than conventional NLPs because disrupting small 
amounts of tumor vessels may induce embolism in tumor ves-
sels, which deprives the tumor cells of nutrients and   oxygen. 
The precondition was that the liposomes did not reduce the 
EPR effect. Apart from the prolonged circulation effects of 
PEG when anchored on the liposome surface, the   ability 
to promote tumor vascular-specific uptake requires the 
ideal liposome to possess additional, specialized features.11 
  Therefore, caution should be exercised when using the strat-
egy of targeting drug-loaded CLPs to the tumor vessels to 
improve drug and gene delivery in solid tumors.
Conclusion
Despite the remarkable targeting of tumor vessels through 
cationic molecules in vitro, this study found that a long 
circulation time in the bloodstream was still vital for achiev-
ing a good distribution in the tumor, because the NLPs and 
CLP-PEG achieved high AUC and MRT values in vivo and 
delivered the largest amount of drug to the tumors, whereas 
the CLPs with high positive potential exhibited high adsorp-
tion of anionic proteins and were rapidly cleared from the 
circulation system. Studies revealed that the enhanced EPR 
effect exhibited by the PEGylated liposomes had a dominant 
effect on enhanced antitumor efficiency in vivo.
Acknowledgments
The National Natural Science Foundation of China (Nos 
30772665 and 30970785) and the Doctoral Foundation of 
the Ministry of Education of China (No. 20100001110056) 
supported this work.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. 
Science. 2004;303(5665):1818–1822.
2.  Obata Y, Tajima S, Takeoka S. Evaluation of pH-responsive lipo-
somes containing amino acid-based zwitterionic lipids for improving 
intracellular drug delivery in vitro and in vivo. J Control Release. 
2010;142(2):267–276.
3.  MacLachlan I, Cullis P, Graham RW. Progress towards a synthetic virus 
for systemic gene therapy. Curr Opin Mol Ther. 1999;1(2):252–259.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0
Days after tumor implantation
S
u
r
v
i
v
a
l
 
r
a
t
e
NLP
NLP-PEG
CLP
CLP-PEG
Free DOX
Normal saline
90 80 70 60 50 40 30 20 10
Figure 6 Mean survival time of female Kunming mice with sarcoma 180 xenografts after treatment. Dosage was adjusted to attain a doxorubicin (DOX) concentration of 
5 mg/kg.*
Note: *Data are presented as mean plus or minus standard deviation (n = 10).
Abbreviations: cLPs, cationic liposomes; cLP-Peg, polyethylene glycolylated cationic liposomes; NLPs, neutral liposomes; NLP-Peg, polyethylene glycolylated neutral 
liposomes.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
3098
Zhao et al
  4.  Heyes J, Hall K, Tailor V , Lenz R, MacLachlan I. Synthesis and char-
acterization of novel poly(ethylene glycol)-lipid conjugates suitable for 
use in drug delivery. J Control Release. 2006;112(2):280–290.
  5.  Ran S, Downes A, Thorpe PE. Increased exposure of anionic 
phospholipids on the surface of tumor blood vessels. Cancer Res. 
2002;62(21):6132–6140.
  6.  Mounkes LC, Zhong W, Cipres-Palacin G, Heath TD, Debs RJ. 
  Proteoglycans mediate cationic liposome-DNA complex-based gene deliv-
ery in vitro and in vivo. J Biol Chem. 1998;273(40):26164–26170.
  7.  Augustin HG, Kozian DH, Johnson RC. Differentiation of endothe-
lial cells: analysis of the constitutive and activated endothelial cell 
  phenotypes. Bioessays. 1994;16(12):901–906.
  8.  Strieth S, Eichhorn ME, Sauer B, et al. Neovascular targeting   chemotherapy: 
encapsulation of paclitaxel in cationic liposomes impairs functional tumor 
microvasculature. Int J Cancer. 2004;110(1):117–124.
  9.  Strieth S, Eichhorn ME, Alexander W, et al. Targeted liposomal 
paclitaxel raises tumor vessel leakiness. Otolaryngol Head Neck Surg. 
2008;139(2 Suppl 1):P94.
  10.  Wu J, Lee A, Lu Y, Lee RJ. Vascular targeting of doxorubicin using 
cationic liposomes. Int J Pharm. 2007;337(1–2):329–335.
  11.  Abu Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H. Oxaliplatin 
encapsulated in PEG-coated cationic liposomes induces significant 
tumor growth suppression via a dual-targeting approach in a murine 
solid tumor model. J Control Release. 2009;137(1):8–14.
  12.  Campbell RB, Fukumura D, Brown EB, et al. Cationic charge determines 
the distribution of liposomes between the vascular and extravascular 
compartments of tumors. Cancer Res. 2002;62(23):6831–6836.
  13.  Cullis PR, Chonn A, Semple SC. Interactions of liposomes and lipid-
based carriers with blood proteins: relation to clearance behavior in vivo. 
Adv Drug Deliv Rev. 1998;32(1–2):3–17.
  14.  Stamatatos L, Leventis R, Zuckermann MJ, Silvius JR. Interactions of 
cationic lipid vesicles with negatively charged phospholipid vesicles 
and biological membranes. Biochemistry. 1988;27(11):3917–3925.
  15.  Litzinger DC, Brown JM, Wala I, et al. Fate of cationic liposomes and 
their complex with oligonucleotide in vivo. Biochim Biophys Acta. 
1996;1281(2):139–149.
  16.  McLean JW, Fox EA, Baluk P, et al. Organ-specific endothelial cell 
uptake of cationic liposome-DNA complexes in mice. Am J Physiol. 
1997;273(1 Pt 2):H387–H404.
  17.  Dass CR. Improving anti-angiogenic therapy via selective delivery 
of cationic liposomes to tumour vasculature. Int J Pharm. 2003; 
267(1–2):1–12.
  18.  Zhang Y, Qi XR, Gao Y, Wei SL, Maitani Y, Nagai T. Mechanisms of 
co-modified liver-targeting liposomes as gene delivery carriers based 
on cellular uptake and antigens inhibition effect. J Control Release. 
2007;117(2):281–290.
  19.  Roy S, Mohanty A, Dey J. Microviscosity of bilayer membranes of 
some N-acylamino acid surfactants determined by fluorescence probe 
method. Chem Phys Lett. 2005;414(1–3):23–27.
  20.  Centra M, Ratych RE, Cao GL, et al. Culture of bovine pulmo-
nary artery endothelial cells on Gelfoam blocks. FASEB J. 1992; 
6(12):3117–3121.
  21.  Gao X, Huang L. A novel cationic liposome reagent for efficient 
transfection of mammalian cells. Biochem Biophys Res Commun. 
1991;179(1):280–285.
  22.  Shinozawa S, Mimaki Y, Araki Y, Oda T. Determination of the con-
centration of adriamycin and its metabolites in the serum and tissues 
of Ehrlich carcinoma-bearing mice by high-performance liquid chro-
matography. J Chromatogr. 1980;196(3):463–469.
  23.  Qi XR, Maitani Y, Nagai T, Wei SL. Comparative pharmacokinetics 
and antitumor efficacy of doxorubicin encapsulated in soybean-derived 
sterols and poly(ethylene glycol) liposomes in mice. Int J Pharm. 
1997;146(1):31–39.
  24.  Uchiyama K, Nagayasu A, Yamagiwa Y, Nishida T, Harashima H, 
Kiwada H. Effects of the size and fluidity of liposomes on their accu-
mulation in tumors: a presumption of their interaction with tumors. Int 
J Pharm. 1995;121(2):195–203.
  25.  Qi XR, Maitani Y, Nagai T. Relation of rigidity of membrane and 
stability of dipalmitoylphosphatidylcholine liposomes with soybean-
derived sterols prepared by reverse-phase evaporation vesicle method. 
Chem Pharm Bull. 1996;44(1):237–240.
  26.  Zhao W, Ma HL, Qi XR. Cationic liposomes loaded with doxorubicin 
targeting to the tumor neovasculature in vitro. Yao Xue Xue Bao. 
2007;42(9):982–988. Chinese.
  27.  Silvander M, Johnsson M, Edwards K. Effects of PEG-lipids on perme-
ability of phosphatidylcholine/cholesterol liposomes in buffer and in 
human serum. Chem Phys Lipids. 1998;97(1):15–26.
  28.  Johnstone SA, Masin D, Mayer L, Bally MB. Surface-associated serum 
proteins inhibit the uptake of phosphatidylserine and poly(ethylene 
glycol) liposomes by mouse macrophages. Biochim Biophys Acta. 
2001;1513(1):25–37.
  29.  Noguchi A, Furuno T, Kawaura C, Nakanishi M. Membrane fusion plays 
an important role in gene transfection mediated by cationic liposomes. 
FEBS Lett. 1998;433(1–2):169–173.
  30.  Elouahabi A, Ruysschaert JM. Formation and intracellular trafficking 
of lipoplexes and polyplexes. Mol Ther. 2005;11(3):336–347.
  31.  Torchilin VP. Fluorescence microscopy to follow the targeting of 
liposomes and micelles to cells and their intracellular fate. Adv Drug 
Deliv Rev. 2005;57(1):95–109.
  32.  Lu WL, Qi XR, Zhang Q, et al. A pegylated liposomal platform: 
  pharmacokinetics, pharmacodynamics, and toxicity in mice using 
doxorubicin as a model drug. J Pharmacol Sci. 2004;95(3):381–389.
  33.  Abu Lila AS, Ishida T, Kiwada H. Recent advances in tumor vasculature 
targeting using liposomal drug delivery systems. Expert Opin Drug 
Deliv. 2009;6(12):1297–1309.
  34.  Levchenko TS, Rammohan R, Lukyanov AN, Whiteman KR, 
Torchilin VP. Liposome clearance in mice: the effect of a separate and 
combined presence of surface charge and polymer coating. Int J Pharm. 
2002;240(1–2):95–102.